Energy Services of America Co. (NASDAQ:ESOA – Get Free Report) Director Samuel G. Kapourales sold 50,000 shares of the company’s stock in a transaction on Wednesday, September 18th. The shares were sold at an average price of $10.10, for a total value of $505,000.00. Following the completion of the transaction, the director now owns 714,191 […]

Conduit Pharmaceuticals Inc. (NASDAQ:CDT – Get Free Report) Director Andrew Regan sold 1,005,200 shares of the firm’s stock in a transaction dated Monday, July 15th. The stock was sold at an average price of $0.25, for a total transaction of $251,300.00. Following the transaction, the director now directly owns 11,936,119 shares of the company’s stock, […]

Inari Medical, Inc. (NASDAQ:NARI – Get Free Report) Director William Hoffman sold 40,000 shares of the company’s stock in a transaction dated Monday, September 16th. The stock was sold at an average price of $45.83, for a total value of $1,833,200.00. Following the sale, the director now owns 643,296 shares in the company, valued at […]

Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX – Get Free Report) CFO James M. Frates purchased 40,000 shares of the firm’s stock in a transaction on Thursday, September 12th. The stock was acquired at an average price of $2.53 per share, with a total value of $101,200.00. Following the completion of the purchase, the chief financial officer now […]